Volume 15 Issue 3 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 15 Issue 3

Rethink, Redesign, Recycle – Pharma’s 100% PET Blister

IPI Speaks with Alberto Negra, Technical Manager at Rotor Print about creating a pharmaceutical blister that can be recycled, but without losing the properties of th...

29 September 2023 Volume 15 Issue 3 Blister | idea

Continue Reading →

Volume 15 Issue 3

A New Age of Pharmaceutical Innovation

IPI Speaks with Dr Patrick Larcier, Senior Director, Strategy Product Development Solutions, EU & US, of PharmaLex, on Next-generation Small Molecules Q: Can ...

29 September 2023 Volume 15 Issue 3 Age | biotechnology

Continue Reading →

Volume 15 Issue 3

Enhancing Clinical Success During Early Development

IPI Speaks with Dr. Victor Diaz, Operations Director at Solitek on a New Concept in Solid StateDevelopment Services for the Pharmaceutical, Agrochemical and Fine Che...

29 September 2023 Volume 15 Issue 3 agrochemical | chemical

Continue Reading →

Volume 15 Issue 3

Integrated CDMO Partner for Parenteral Drug Products

IPI Speaks with Mr Anil Busimi, VP, Strategy & Marketing of Terumo Medical Care Solutions (TMCS)on the Recent Changes in the CDMO Industry and what the Market is...

29 September 2023 Volume 15 Issue 3 care | CDMO

Continue Reading →

Volume 15 Issue 3

5 Steps to Improving Pharmacovigilance System Master File (PSMF) Management

Christian Schmitz-Moormann, a senior consultant and pharmacovigilance (PV) expert, and partner of Generis, considers the role of this essential master resource in ma...

29 September 2023 Volume 15 Issue 3 essential | File

Continue Reading →

Volume 15 Issue 3

Why Pharma Dealmaking is a Sector that’s Ripe for Growth

The global pharmaceutical sector is booming thanks to continued growth in R&D spend in new technologies and therapeutic areas, putting the industry back on a mor...

29 September 2023 Volume 15 Issue 3 global | growth

Continue Reading →

Volume 15 Issue 3

Antibody Drug Conjugates and the Link to Fighting Cancer

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver tremend...

29 September 2023 Volume 15 Issue 3 ADCs | antibody

Continue Reading →

Volume 15 Issue 3

Promising Advances in Plasma Proteomics for Early Disease Detection and Personalised Treatments

The early detection of disease poses a substantial challenge in the field of human health, necessitating the development of more accurate biomarkers, enhanced patien...

29 September 2023 Volume 15 Issue 3 advances | biomarkers

Continue Reading →

Volume 15 Issue 3

High Efficiency Safety Profile for Recurrent Vaginitis and Biofilm Treatment

Sustainable system for the treatment of vaginal diseases, part I – pre-clinical laboratory study A holistic approach, to address the state of the vaginal biofilm usi...

29 September 2023 Volume 15 Issue 3 Efficiency | High

Continue Reading →

Volume 15 Issue 3

Keeping eCOAs Off the Critical Path – Key Considerations

The prevalence of decentralised clinical trials, rising demand for preventive healthcare solutions, a market driven by the need for more and better-quality data and ...

29 September 2023 Volume 15 Issue 3 clinical | Critical

Continue Reading →